10-Q: RYTHM Inc. Q1 2026 Earnings: Licensing Revenue Drives Growth

RYTHM Inc. reported a significant revenue increase driven by new licensing agreements, alongside a substantial net income driven by a non-cash tax benefit.

Summary

• RYTHM Inc. reported total revenue of $13.3 million for the three months ended March 31, 2026, a substantial increase from $0.5 million in the same period of 2025.
• This growth was primarily fueled by the commencement of Licensing Revenue in May and August 2025, contributing $10.0 million, and a $2.8 million increase in Non-Licensing Revenue.
• Gross profit surged to $10.4 million (78% of revenue) from $0.1 million (17% of revenue) year-over-year, largely due to the high-margin licensing revenue.
• Selling, General, and Administrative (SG&A) expenses increased significantly to $14.4 million from $3.8 million, attributed to marketing, consulting, and shared services costs.
• The company reported a net income of $19.9 million for the quarter, a stark contrast to a net loss of $1.6 million in the prior year. This was primarily due to a $25.6 million non-cash income tax benefit from the release of a valuation allowance.
• Cash flow from operating activities was positive at $1.0 million, compared to a negative $6.7 million in the prior year.
• The company ended the quarter with $33.3 million in cash and cash equivalents.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a cautiously optimistic report, with strong revenue growth and a positive net income driven by strategic licensing changes and a significant tax benefit, but tempered by high operating expenses and substantial debt.

Positives

• Significant revenue growth of 2370% to $13.3 million, driven by new licensing agreements.
• Gross profit margin improved to 78% from 17% due to high-margin licensing revenue.
• Achieved net income of $19.9 million, a substantial turnaround from a net loss.
• Positive cash flow from operating activities of $1.0 million, compared to a significant outflow in the prior year.
• Release of valuation allowance against deferred tax assets, resulting in a $25.6 million non-cash tax benefit and improved net income.
• Secured $308.4 million in aggregate contractual Licensing Revenue through August 27, 2030.
• The company believes its current cash position and anticipated revenue are sufficient to meet cash requirements for at least the next 12 months.

Negatives

• SG&A expenses increased by 281% to $14.4 million, impacting profitability before the tax benefit.
• Significant related party transactions, including $10.0 million in Licensing Revenue and $1.8 million in interest expense.
• Substantial debt obligations of $80.0 million in Convertible Notes, with $72.0 million held by a related party (Green Thumb), maturing through February 2027.
• The potential for holders of Convertible Notes to elect cash repayment upon maturity could raise substantial doubt about the company's ability to continue as a going concern.
• Ongoing legal proceedings related to past cultivation business operations, with $1.5 million funded into escrow for potential settlements.

Risks

• The company has a history of recurring net losses and negative cash flow from operations.
• The ability of holders of Convertible Notes to elect cash repayment upon maturity could raise substantial doubt about the company's ability to continue as a going concern.
• Ongoing legal proceedings, including the Bud & Marys Litigation, Bowdoin Construction Corp. Litigation, and McCutchan, Inc. litigation, could result in significant financial liabilities.
• Changes in legislation around hemp-derived products could materially restrict commercialization and potentially trigger repurchase rights on acquired intellectual property.
• The company's reliance on related parties, particularly Green Thumb Industries Inc., for significant revenue, debt, and services, presents concentration risk.
• The company may not be able to raise additional capital on acceptable terms if required, which could adversely affect its business and financial condition.

Future Outlook

The company anticipates that its current cash and cash equivalents of $33.3 million, along with anticipated contractual Licensing Revenue and the ability to address its Convertible Notes, will be sufficient to meet its cash requirements through at least the 12-month period following the issuance date of these financial statements. However, the maturity of $80.0 million in Convertible Notes through February 2027, with a significant portion held by a related party, presents a potential challenge if holders elect cash repayment.

Management Comments

• Management believes that the Companys $33.3 million of cash and cash equivalents, anticipated contractual Licensing Revenue and ability to address outstanding Convertible Notes will be sufficient to meet our cash requirements through at least the 12-month period following the date that these condensed consolidated financial statements were issued.
• While these contractual maturities require management attention, management believes it is probable that the obligations will be addressed through extension or conversion consistent with historical practice.
• Based on sustained projected book and taxable income over the near term, management concluded that sufficient positive evidence exists to determine that its deferred tax assets are more-likely-than-not realizable, and accordingly released the valuation allowance in full during the three months ended March 31, 2026.

Industry Context

StockSavvy.ai notes that RYTHM Inc.'s strategic shift towards licensing revenue, particularly with the amendment to fixed annual fees totaling $70 million, aligns with industry trends favoring recurring revenue models. The significant increase in revenue and gross profit highlights the potential of this strategy, though the substantial SG&A expenses and ongoing debt obligations require careful management.

Comparison to Industry Standards

• RYTHM's licensing revenue model, with fixed annual fees of $70 million, is a significant development. This fixed fee structure provides greater revenue predictability compared to traditional sales-based royalties, which is a positive differentiator in the evolving cannabis and hemp-derived products market.
• The company's gross profit margin of 78% on licensing revenue is exceptionally high and likely exceeds industry averages for similar intellectual property licensing in the consumer packaged goods sector.
• The substantial increase in SG&A expenses (281%) warrants comparison. While marketing and support services are necessary for growth, this increase outpaces revenue growth in absolute terms, suggesting potential inefficiencies or aggressive investment in market penetration that needs to be monitored against industry benchmarks for companies of similar size and stage.
• The company's net income being driven by a tax benefit is a unique situation. While the release of a valuation allowance is a positive accounting event, it masks the operational profitability before this non-cash item. Industry peers often show operational profitability or losses that are more directly tied to core business activities.

Legal Proceedings

• Bud & Marys Litigation: Seeking monetary damages for alleged unfair trade practices, breach of contract, and conversion related to a TTK solution agreement. The company is vigorously defending itself and has filed counterclaims.
• Bowdoin Construction Corp. Litigation: Allegations of breach of contract and indemnification claims related to a construction contract, with consolidated subcontractor suits totaling approximately $7.0 million. The company denies liability.
• McCutchan, Inc. Litigation: Claims of breach of contract, voidable contract, interference with business expectancy, unjust enrichment, and defamation, seeking no less than $3 million against the company and other defendants.

Related Party Transactions

• Significant revenue from related parties, with $10.0 million in Licensing Revenue for the three months ended March 31, 2026.
• Interest expense of $1.8 million for the three months ended March 31, 2026, related to Convertible Notes held by a related party.
• Support services provided by Green Thumb Industries Inc. (a related party) totaling $3.1 million for the three months ended March 31, 2026.
• Inventory purchase of $202 thousand from Green Thumb Industries Inc.
• Approximately $72.0 million of the $80.0 million in Convertible Notes outstanding are held by a subsidiary of Green Thumb.
• Approximately 9.9 million warrants are held by subsidiaries of Green Thumb.
• Two of RYTHM's seven directors are affiliated with Green Thumb.
• RYTHM's Chief Financial Officer is a Green Thumb employee providing services under a shared services agreement.

Stakeholder Impact

• Shareholders: Potential for increased value due to revenue growth and improved financial position, but also risks associated with debt and ongoing litigation.
• Creditors: The company's ability to meet its debt obligations, particularly the Convertible Notes, is a key concern.
• Employees: The company has minimal direct employees, relying heavily on shared services from Green Thumb.
• Suppliers: Standard supplier relationships are in place, with some inventory purchases from related parties.

Next Steps

• Recognize $308.4 million in aggregate contractual Licensing Revenue ratably over the period through August 27, 2030.
• Manage $80.0 million in Convertible Notes maturing through February 2027.
• Continue to manage legal proceedings related to past operations.
• Monitor the impact of potential legislative changes on hemp-derived products and associated repurchase rights.

Key Dates

Recommendation

The company shows strong top-line growth driven by a strategic shift to licensing revenue, which is a positive indicator. However, the significant increase in operating expenses, substantial debt obligations, and ongoing legal challenges introduce considerable risk. The positive net income is largely due to a non-cash tax benefit, masking the operational profitability. Therefore, a 'hold' recommendation is appropriate, pending further clarity on operational profitability and resolution of legal matters.

Keywords

RYTHM Inc., SEC Filing, 10-Q, Quarterly Report, Hemp-derived THC products, Licensing Revenue, Financial Results, Convertible Notes, Related Party Transactions, Green Thumb Industries